INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial.

Name: INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial.
Author: Patt, Yehuda Z

INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial. — المؤلف: Patt, Yehuda Z — Cancer medicine 20180514

المؤلف: Patt, Yehuda Z
النشر: Cancer medicine 20180514
الوصف: 2042-2051 p.
الموضوعات: Adult؛ Aged؛ Antineoplastic Combined Chemotherapy Protocols؛ Bile Duct Neoplasms؛ Carcinoma, Hepatocellular؛ Deoxycytidine؛ Erlotinib Hydrochloride؛ Female